<!DOCTYPE html>
<html lang="en"><head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>Renal and Bladder Physiology | Pediatric Urology Book</title>
  
  <!-- SEO stuff -->
  <meta name="generator" content="Jekyll v4.2.2" />
  <meta name="author" content="Arlen AM, Gundeti MS, López P-J, Rove KO" />
  <meta name="description" content="Chapter 3 details renal and bladder physiology." />
  <meta property="article:published_time" content="2023-04-28" />
  <link rel="canonical" href="https://pediatricurologybook.com/book/chapters/01-03_renal-and-bladder-physiology/" />
  <script type="application/ld+json">
    {
      "@context":"https://schema.org",
      "@type":"WebSite",
      "editor": [
        {
          "@type":"Person",
          "email":"angela.arlen@yale.edu",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://medicine.yale.edu/",
              "name":"Yale University School of Medicine"
            },{
              "@type":"Organization",
              "url":"https://www.ynhh.org/",
              "name":"Yale-New Haven Hospital"
            }
          ],
          "familyName": "Arlen",
          "givenName": "Angela",
          "additionalName":"M.",
          "name":"Angela M. Arlen"
        }
      ,{
          "@type":"Person",
          "email":"mgundeti@surgery.bsd.uchicago.edu",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.uchicagomedicine.org/",
              "name":"University of Chicago Medical Center"
            },{
              "@type":"Organization",
              "url":"https://www.uchicagomedicine.org/comer",
              "name":"Comer Children’s Hospital"
            }
          ],
          "familyName": "Gundeti",
          "givenName": "Mohan",
          "additionalName":"S.",
          "name":"Mohan S. Gundeti"
        }
      ,{
          "@type":"Person",
          "email":"pejotalopez@gmail.com",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.urologiahegc.cl/",
              "name":"Hospital Exequiel González Cortés & Clinica Alemana "
            },{
              "@type":"Organization",
              "url":"https://www.uchile.cl/",
              "name":"Universidad de Chile"
            }
          ],
          "familyName": "López",
          "givenName": "Pedro-José",
          "name":"Pedro-José López"
        }
      ,{
          "@type":"Person",
          "email":"kyle.rove@childrenscolorado.org",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.childrenscolorado.org",
              "name":"Children's Hospital Colorado"
            },{
              "@type":"Organization",
              "url":"https://medschool.cuanschutz.edu",
              "name":"University of Colorado, School of Medicine"
            }
          ],
          "familyName": "Rove",
          "givenName": "Kyle",
          "additionalName":"O.",
          "name":"Kyle O. Rove"
        }
      ],
      "author":[
        {
          "@type":"Person",
          "email":"eric.benz@childrenscolorado.org",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.childrenscolorado.org",
              "name":"Children's Hospital Colorado"
            },{
              "@type":"Organization",
              "url":"https://medschool.cuanschutz.edu",
              "name":"University of Colorado, School of Medicine"
            }
          ],
          "familyName": "Benz",
          "givenName": "Eric",
          "additionalName":"G.",
          "name":"Eric G. Benz"
        }
      ],
      "datePublished":"2023-04-28",
      "dateModified":"2023-02-22",
      "description":"Chapter 3 details renal and bladder physiology.",
      "image":"https://pediatricurologybook.com/assets/thumbs/01-03_renal-and-bladder-physiology.png",
      "headline":"Renal and Bladder Physiology",
      "name":"Pediatric Urology Book",
      "url":"https://pediatricurologybook.com/book/chapters/01-03_renal-and-bladder-physiology/"
    }
  </script>

  <!-- I18n headers -->
  <meta http-equiv="Content-Language" content="en">
<link rel="alternate" hreflang="en" href="https://pediatricurologybook.com/book/chapters/01-03_renal-and-bladder-physiology/"/>
<link rel="alternate" hreflang="es" href="https://pediatricurologybook.com/es/book/chapters/01-03_renal-and-bladder-physiology/"/>
<link rel="alternate" hreflang="zh" href="https://pediatricurologybook.com/zh/book/chapters/01-03_renal-and-bladder-physiology/"/>
<link rel="alternate" hreflang="pt" href="https://pediatricurologybook.com/pt/book/chapters/01-03_renal-and-bladder-physiology/"/>

  <!-- Favicon -->
  <link rel="icon" href="https://pediatricurologybook.com/favicon.ico" type="image/x-icon" > <!-- 32×32 -->
  <link rel="icon" href="https://pediatricurologybook.com/assets/site-img/favicons/icon.svg" type="image/svg+xml">    <!-- res independent -->
  <link rel="apple-touch-icon" href="https://pediatricurologybook.com/assets/site-img/favicons/apple-touch-icon.png"> <!-- 180×180 -->
  <link rel="manifest" href="/manifest.webmanifest">
  
  <!-- Mobile Metas -->
  <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1.0, shrink-to-fit=no">
  
  <!-- Social Media Tags -->
  <meta name="twitter:card" content="summary_large_image" />
  <meta name="twitter:image" content="https://pediatricurologybook.com/assets/thumbs/01-03_renal-and-bladder-physiology.png" />
  <meta name="twitter:site" content="@PedUrologyBook" />
  <meta name="twitter:title" content="Renal and Bladder Physiology" />
  <meta name="twitter:description" content="Chapter 3 details renal and bladder physiology." />
  <meta property="og:locale" content="en" />
  <meta property="og:site_name" content="Pediatric Urology Book" />
  <meta property="og:title" content="Renal and Bladder Physiology" />
  <meta property="og:url" content="https://pediatricurologybook.com/book/chapters/01-03_renal-and-bladder-physiology/" />
  <meta property="og:image" content="https://pediatricurologybook.com/assets/thumbs/01-03_renal-and-bladder-physiology.png" />
  <meta property="og:description" content="Chapter 3 details renal and bladder physiology." />
  
  <!-- Vendor CSS -->
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/vendor/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/vendor/fontawesome-pro/css/all.min.css">
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/vendor/animate/animate.min.css">
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/vendor/rs-plugin/css/navigation.css">
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/vendor/owl.carousel/assets/owl.carousel.min.css">
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/vendor/owl.carousel/assets/owl.theme.default.min.css">
  
  <!-- Theme CSS -->
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/css/theme.css">
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/css/theme-elements.css">

  <!-- Skin CSS -->
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/css/skins/skin-pub.css"> 
  
  <!-- Theme Custom CSS -->
  <link rel="stylesheet" href="https://pediatricurologybook.com/assets/css/custom.css">
  
  <!-- JS Libraries -->
  <script src="https://pediatricurologybook.com/assets/vendor/modernizr/modernizr.min.js"></script>
</head>
<body data-plugin-page-transition>

    <div class="body" aria-label="Content">    
    
    <header id="header" data-plugin-options="{'stickyEnabled': true, 'stickyEnableOnBoxed': true, 'stickyEnableOnMobile': true, 'stickyStartAt': 108, 'stickySetTop': '-109px', 'stickyChangeLogo': true}">
      <div class="header-body">
        <div class="header-container container">
          <div class="header-row">
            <div class="header-column">
              <div class="header-row">
                <div class="header-logo">
                  <a class="site-title" rel="author" href="https://pediatricurologybook.com/">
                    <img width="254" height="165" data-sticky-width="126" data-sticky-height="80" data-sticky-top="95" alt="Pedatric Urology Book" src="https://pediatricurologybook.com/assets/site-img/pediatricurologybook-new.svg">
                  </a>
                </div>
              </div>
            </div>
            <div class="header-column justify-content-end">
              <div class="header-row pt-3 mb-3">
                <nav class="header-nav-top">
                  <ul class="nav nav-pills">
                    <li class="nav-item nav-item-anim-icon d-none d-md-block">
                      <a class="nav-link pl-0" href="https://pediatricurologybook.com/about-us/"><i class="fa fa-angle-right pr-1"></i>About Us</a>
                    </li>
                    <li class="nav-item nav-item-anim-icon d-none d-md-block">
                      <a class="nav-link" href="https://pediatricurologybook.com/contact-us/"><i class="fa fa-angle-right pr-1"></i>Contact Us</a>
                    </li>
                    <li class="nav-item dropdown nav-item-left-border d-block nav-item-left-border-remove nav-item-left-border-md-show">
                      
                      <a class="nav-link" href="#" role="button" id="dropdown-language" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        <i class="fas fa-globe-americas"></i> English
                        <i class="fas fa-angle-down"></i>
                      </a>
                      <div class="dropdown-menu" aria-labelledby="dropdown-language">
                        
                          
                            
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://pediatricurologybook.com/es/book/chapters/01-03_renal-and-bladder-physiology/">Español</a>
                          
                        
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://pediatricurologybook.com/zh/book/chapters/01-03_renal-and-bladder-physiology/">简体中文</a>
                          
                        
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://pediatricurologybook.com/pt/book/chapters/01-03_renal-and-bladder-physiology/">Português</a>
                          
                        
                      </div>
                    </li>
                  </ul>
                </nav>
                <div class="header-nav-features header-nav-features-no-border header-nav-features-md-show-border d-none d-md-inline-flex">
                    <div class="simple-search input-group w-auto">
                      <input class="form-control text-1" id="search-input" name="q" type="text" value="" placeholder="Search...">
                      <span class="input-group-btn">
                        <button class="btn" type="submit">
                          <i class="fa fa-search"></i>
                        </button>
                      </span>
                      <ul id="search-results">
                      </ul>
                    </div>
                </div>
              </div>
              <div class="header-row">
                <div class="header-nav pt-1">
                  <div class="header-nav-main header-nav-main-effect-1 header-nav-main-sub-effect-1">
                    <nav class="collapse">
                      <ul class="nav nav-pills" id="mainNav">
                        <li><a href="https://pediatricurologybook.com/"><i class="fas fa-home pr-1"></i>Home</a></li>
                        <li><a href="https://pediatricurologybook.com/book/"><i class="fas fa-book pr-1"></i>Read The Book</a></li>
                        <li><a href="https://pediatricurologybook.com/editors/"><i class="fas fa-pen-fancy pr-1"></i>Editors</a></li>
                        <li><a href="https://pediatricurologybook.com/contributors/"><i class="fas fa-code-branch pr-1"></i>Contributors</a></li>
                        <li><a href="https://pediatricurologybook.com/sponsors/"><i class="fas fa-user-md pr-1"></i>Sponsors</a></li>
                      </ul>
                    </nav>
                  </div> <!-- end header-nav-main -->
                  <button class="btn header-btn-collapse-nav" data-toggle="collapse" data-target=".header-nav-main nav">
                      <i class="fas fa-bars"></i>
                  </button>
                </div> <!-- end header-nav -->
              </div> <!-- end header-row -->
            </div> <!-- end header-column -->
          </div> <!-- end header-row -->
        </div> <!-- end header-container -->
      </div> <!-- end header-body -->
    </header>
        
    
    
    
    
    
    <div role="main" class="main">
      <section class="page-header page-header-modern bg-color-primary page-header-md">
        <div class="container">
          <div class="row">
            <div class="col-md-8 order-2 order-md-1 align-self-center p-static">
              <h1>3: Renal and Bladder Physiology</h1>
            </div>
            
            <div class="col-md-4 order-1 order-md-2 align-self-center">
              <ul class="breadcrumb d-block text-md-right breadcrumb-light">
              
                <li><a href="https://pediatricurologybook.com/">Home</a></li>
              
                <li><a href="https://pediatricurologybook.com/book/">Book</a></li>
              
                <li class="active"><a href="https://pediatricurologybook.com/book/#basics-of-pediatric-urology">Section 1: Basics of Pediatric Urology</a></li>
              </ul>
            </div>
          </div>
        </div>
      </section>
      <div class="container chapter chapter-01-03">
        <div class="row">
          <div class="col-lg-3 order-2 order-lg-1 mt-4 mt-lg-0 chapter-toc">
            <aside class="sidebar">
              <h5 class="font-weight-bold no_toc">Chapter Contents</h5>
    
            <ul class="nav nav-list flex-column mb-5">
<li class="nav-item toc-h2"><a href="#introduction">Introduction</a></li>
<li class="nav-item toc-h2"><a href="#summary-of-kidney-function">Summary of Kidney Function</a></li>
<li class="nav-item toc-h2"><a href="#assessing-renal-function">Assessing Renal Function</a>
<ul>
<li class="nav-item toc-h3"><a href="#assessment-of-filtration">Assessment of Filtration</a>
<ul>
<li class="nav-item toc-h4"><a href="#cystatin-c">Cystatin C</a></li>
<li class="nav-item toc-h4"><a href="#estimating-equations-for-glomerular-filtration-rate">Estimating Equations for Glomerular Filtration Rate</a></li>
<li class="nav-item toc-h4"><a href="#clinical-pearl">Clinical Pearl</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#assessment-of-tubular-function">Assessment of Tubular Function</a></li>
<li class="nav-item toc-h3"><a href="#clinical-pearl-1">Clinical Pearl</a>
<ul>
<li class="nav-item toc-h4"><a href="#tubular-function-by-age">Tubular Function by Age</a></li>
<li class="nav-item toc-h4"><a href="#clinical-pearl-2">Clinical Pearl</a></li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#acute-kidney-injury">Acute Kidney Injury</a>
<ul>
<li class="nav-item toc-h4"><a href="#etiology-of-aki">Etiology of AKI</a>
<ul>
<li class="nav-item toc-h5"><a href="#prerenal-azotemia">Prerenal Azotemia</a></li>
<li class="nav-item toc-h5"><a href="#intrinsic-renal-failure">Intrinsic Renal Failure</a></li>
<li class="nav-item toc-h5"><a href="#vascular">Vascular</a></li>
<li class="nav-item toc-h5"><a href="#glomerulonephritis">Glomerulonephritis</a></li>
<li class="nav-item toc-h5"><a href="#acute-tubular-necrosis">Acute Tubular Necrosis</a></li>
<li class="nav-item toc-h5"><a href="#clinical-pearl-3">Clinical Pearl</a></li>
<li class="nav-item toc-h5"><a href="#acute-interstitial-nephritis">Acute Interstitial Nephritis</a></li>
<li class="nav-item toc-h5"><a href="#clinical-pearl-4">Clinical Pearl</a></li>
<li class="nav-item toc-h5"><a href="#indications-for-dialysis">Indications for Dialysis</a></li>
</ul>
</li>
</ul>
</li>
<li class="nav-item toc-h3"><a href="#chronic-kidney-disease">Chronic Kidney Disease</a>
<ul>
<li class="nav-item toc-h4"><a href="#management-of-chronic-kidney-disease">Management of Chronic Kidney Disease</a>
<ul>
<li class="nav-item toc-h5"><a href="#blood-pressure-control">Blood Pressure Control</a></li>
<li class="nav-item toc-h5"><a href="#anemia-of-chronic-kidney-disease">Anemia of Chronic Kidney Disease</a></li>
<li class="nav-item toc-h5"><a href="#metabolic-bone-disease">Metabolic Bone Disease</a></li>
<li class="nav-item toc-h5"><a href="#growth">Growth</a></li>
<li class="nav-item toc-h5"><a href="#renal-replacement-therapy">Renal Replacement Therapy</a></li>
<li class="nav-item toc-h5"><a href="#peritoneal-dialysis">Peritoneal Dialysis</a></li>
<li class="nav-item toc-h5"><a href="#hemodialysis">Hemodialysis</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li class="nav-item toc-h2"><a href="#suggested-readings">Suggested Readings</a></li>
<li class="nav-item toc-h2"><a href="#references">References</a></li>
</ul>
            
            
                <h5 class="font-weight-bold no_toc"> Prior Version Related Links</h5>
<ul class="prior-version-links">

    <li><a href="https://v1.pediatricurologybook.com/renal_physiology.html" title="Renal Physiology">Renal Physiology<small> (v1)</small></a></li>

    <li><a href="https://v1.pediatricurologybook.com/chronic_kidney_disease.html" title="Renal Impairment">Renal Impairment<small> (v1)</small></a></li>

</ul>
            
            
            </aside>
          </div>
          <div class="col-lg-9 order-1 order-lg-2 chapter-body">
            <p class="time-to-read"><i class="fas fa-circle-info pr-2"></i><em>This chapter will take approximately 20 minutes to read.</em></p><div class="attribution">
    <div class="authors">
        By <span class="author-container"><span class="author-name">
    <a href="/contributors/#benz-eric-g">Eric G. Benz, MD</a>
</span> <a href="#" id="social-drop-13" class="social-drop-down" aria-haspopup="true" aria-expanded="false"><i class="fa-regular fa-signal-stream"></i></a> <sup>1, 2</sup></span>&nbsp; &amp; <span class="author-container"><span class="author-name">
    <a href="/contributors/#">  </a>
</span> <a href="#" id="social-drop-137" class="social-drop-down" aria-haspopup="true" aria-expanded="false"><i class="fa-regular fa-signal-stream"></i></a> <sup></sup></span></div><ul class="thumb-info-social-icons" id="social-drop-13">
    <li class="social-icons-website"><a href="https://www.childrenscolorado.org/doctors-and-departments/physicians/b/47/" target="_blank" title="Website"><i class="fas fa-link"></i></a></li>
    <li class="social-icons-email"><a href="mailto:eric.benz@childrenscolorado.org" target="_blank" title="Email"><i class="fas fa-envelope"></i></a></li>
    
    
    
    
    
    
    
    
    
    <li class="social-icons-doximity"><a href="https://www.doximity.com/profiles/bbab433d-7622-425e-92af-fac7e5f12b05/show" target="_blank" title="Doximity"><i class="ai2 ai-doximity"></i></a></li>
    
    
    <li class="social-icons-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Benz+EG&cauthor_id=34160691" target="_blank" title="PubMed"><i class="ai2 ai-pubmed"></i></a></li>
</ul><ul class="thumb-info-social-icons" id="social-drop-">
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
</ul><ol class="author-affiliation-list"><li class="author-affiliation" value="1"><span>
    <address>Department of Pediatrics, Division of Nephrology, <a href="https://www.childrenscolorado.org">Children's Hospital Colorado</a>, Aurora, CO, USA
    </address>
</span></li>
                <li class="author-affiliation" value="2"><span>
    <address><a href="https://medschool.cuanschutz.edu">University of Colorado, School of Medicine</a>, Aurora, CO, USA
    </address>
</span></li></ol>
</div>

                
            <h2 id="introduction">
<a class="anchor" href="#introduction" aria-hidden="true"><span class="octicon octicon-link"></span></a>Introduction</h2>

<p class="drop-caps">The kidneys play an essential role in the normal health and development of children. The nephron is the functioning unit of the kidney, with each kidney containing ~500,000–1,000,000 nephrons. Cumulatively, the basic processes of the nephron are 1) filtration, 2) reabsorption, and 3) secretion.</p>

<p><img src="https://pediatricurologybook.com/assets/figures/figure-03-1.svg" alt="Figure 1" class="float-start img-fluid"><br>
<strong id="figure-1" class="figure-number">Figure 1</strong> The nephron is the functioning unit of the kidney and is composed of the glomerulus, proximal tubule, loop of Henle, distal convoluted tubule and collecting duct.</p>

<p>Each nephron has 5 main parts: 1) the glomerulus, 2) the proximal tubule, 3) the loop of Henle, 4) the distal convoluted tubule, and 5) the collecting ducts (<a href="#figure-1" class="figure-link">Figure 1</a>). The glomeruli (‘filters’) have both charge and size selectivity and filter plasma across the endothelial (capillary), glomerular basement membrane, and epithelial (podocyte) layers. (See below regarding assessment of filtration.) The proximal tubule (‘workhorse’) is where approximately 85% of reabsorption occurs—including sodium, water, amino acids, and glucose. The loop of Henle allows for dilution and subsequent concentration of urine via the counter current multiplier. The distal convoluted tubule contains the macula densa which is critical for juxtaglomerular feedback with subsequent autoregulation of renal blood flow. Autoregulation allows for a fairly constant glomerular filtration rate (<abbr title="glomerular filtration rate">GFR</abbr>) under normal physiological circumstances. Finally, the collecting ducts respond to anti-diuretic hormone (<abbr title="antidiuretic hormone">ADH</abbr>), which allows for concentration of urine, as well as aldosterone which allows for secretion of potassium.</p>

<h2 class="key-points-head" id="summary-of-kidney-function">
<a class="anchor" href="#summary-of-kidney-function" aria-hidden="true"><span class="octicon octicon-link"></span></a>Summary of Kidney Function</h2>

<ol class="key-points-list">
  <li>Filtration of nitrogenous waste</li>
  <li>Volume/blood pressure control</li>
  <li>Electrolyte balance</li>
  <li>pH regulation</li>
  <li>Vitamin D conversion</li>
  <li>Epogen production</li>
</ol>

<p>Beyond filtration, the kidneys also control volume and blood pressure (via both response to <abbr title="antidiuretic hormone">ADH</abbr> as well as the renin angiotensin aldosterone system), regulate electrolyte balance, help regulate serum pH, convert inactive 25-hydroxy vitamin D to active 1,25-dihydroxyvitamin D, and secrete epogen.</p>

<h2 id="assessing-renal-function">
<a class="anchor" href="#assessing-renal-function" aria-hidden="true"><span class="octicon octicon-link"></span></a>Assessing Renal Function</h2>

<p>Despite the complexity of filtration, reabsorption and secretion along the nephron, assessment of nephron function can be simplified into two parts: filtration (glomeruli) and tubular function.</p>

<h3 id="assessment-of-filtration">
<a class="anchor" href="#assessment-of-filtration" aria-hidden="true"><span class="octicon octicon-link"></span></a>Assessment of Filtration</h3>

<p>Glomerular filtration rate (<abbr title="glomerular filtration rate">GFR</abbr>) is the rate at which plasma is cumulatively filtered through the nephrons. After filtration, most of the filtered load is reabsorbed along the nephron. In pediatrics, the Schwartz equation is most commonly used to estimate <abbr title="glomerular filtration rate">GFR</abbr> (<abbr title="estimated glomerular filtration rate">eGFR</abbr>) in children.<a class="citation" href="#schwartz2009a"><span style="vertical-align: super">1</span></a> The Schwartz equation (<a href="#figure-2" class="figure-link">Figure 2</a>) is based on serum creatinine as well as the child’s height. While a normal <abbr title="glomerular filtration rate">GFR</abbr> in adults is ~120 mL/min/1.73 m<sup>2</sup>, in pediatrics a normal <abbr title="glomerular filtration rate">GFR</abbr> varies depending on a child’s age. Typically, a full-term neonate’s initial <abbr title="glomerular filtration rate">GFR</abbr> is only ~30 mL/min/1.73 m<sup>2</sup> while a premature neonate’s initial <abbr title="glomerular filtration rate">GFR</abbr> can be even lower ~15 mL/min/1.73 m<sup>2</sup>.<a class="citation" href="#schwartz2007a"><span style="vertical-align: super">2</span></a> Regardless of gestational age, <abbr title="glomerular filtration rate">GFR</abbr> roughly doubles within 2 weeks of age because of decreasing vascular resistance with a resultant increase in renal blood flow and perfusion. <abbr title="glomerular filtration rate">GFR</abbr> then continues to increase (corrected for body surface area) and reaches adult norms at about 19 months of age. Serum creatinine is the easiest way to estimate <abbr title="glomerular filtration rate">GFR</abbr> but has drawbacks, as serum creatinine is affected by muscle mass, body habitus, and underlying medical conditions.</p>

<p><img src="https://pediatricurologybook.com/assets/figures/figure-03-2.svg" alt="Figure 2" class="float-start img-fluid"><br>
<strong id="figure-2" class="figure-number">Figure 2</strong> The Schwartz equation is a simple bedside formula to estimate glomerular filtration rate in children.</p>

<h4 id="cystatin-c">
<a class="anchor" href="#cystatin-c" aria-hidden="true"><span class="octicon octicon-link"></span></a>Cystatin C</h4>

<p>While creatinine has been the mainstay laboratory value to assess renal function, a new molecule to estimate <abbr title="glomerular filtration rate">GFR</abbr> has been increasingly utilized. Cystatin C is a molecular housekeeping protein produced by all nucleated cells that is excreted at a constant rate in the urine and not reabsorbed by the nephron. Equations have now been created for both children and adults to measure the serum level of Cystatin C and use that to assess <abbr title="estimated glomerular filtration rate">eGFR</abbr>. Additionally, it has been shown that certain populations, specifically those with poor muscle mass/muscular dystrophies and children with spina bifida, have more accurate estimates of their <abbr title="glomerular filtration rate">GFR</abbr> using Cystatin C alone.<a class="citation" href="#fox2014a"><span style="vertical-align: super">3,4</span></a> Cystatin C does have pitfalls, as it can be up or down regulated in certain clinical scenarios. Children with poorly managed thyroid dysfunction or those on steroids can affect their serum cystatin C and thus make it a poor marker for measuring <abbr title="estimated glomerular filtration rate">eGFR</abbr> in those populations.<a class="citation" href="#filler2018a"><span style="vertical-align: super">5</span></a> Additionally, like creatinine, most <abbr title="estimated glomerular filtration rate">eGFR</abbr> calculations using Cystatin C are only validated in children 1–2 years and greater, due to <abbr title="glomerular filtration rate">GFR</abbr> not maturing until about 2 years of age.</p>

<h4 id="estimating-equations-for-glomerular-filtration-rate">
<a class="anchor" href="#estimating-equations-for-glomerular-filtration-rate" aria-hidden="true"><span class="octicon octicon-link"></span></a>Estimating Equations for Glomerular Filtration Rate</h4>

<p>In addition to the Schwartz equation, several other equations to estimate <abbr title="glomerular filtration rate">GFR</abbr> have been developed using either creatinine, cystatin C, or both in combination. One example is the Zappitelli equation, which provides a cystatin C only <abbr title="estimated glomerular filtration rate">eGFR</abbr> calculation for children 1–18 years old.<a class="citation" href="#zappitelli2006a"><span style="vertical-align: super">6</span></a> Additionally, CKiD (Chronic Kidney Disease in Children cohort study) has published updated equations to estimate <abbr title="glomerular filtration rate">GFR</abbr> in children with chronic kidney disease from ages 1–25 using either Creatinine, Cystatin C, or a combination of both.<a class="citation" href="#pierce2021a"><span style="vertical-align: super">7</span></a> Consideration of the study cohort is important to ensure appropriate interpretation of the estimated <abbr title="glomerular filtration rate">GFR</abbr> (<a href="#table-1" class="table-link">Table 1</a>). Children who have an abnormal <abbr title="estimated glomerular filtration rate">eGFR</abbr> should be referred to a pediatric nephrologist for further evaluation, work-up, and management.</p>

<p><strong id="table-1" class="table-number">Table 1</strong> A sample of various equations to estimate <abbr title="estimated glomerular filtration rate">eGFR</abbr> in children using serum creatinine, serum cystatin C, or both serum measures.</p>

<table>
  <thead>
    <tr>
      <th>Estimated <abbr title="glomerular filtration rate">GFR</abbr> (<abbr title="estimated glomerular filtration rate">eGFR</abbr>) Equation</th>
      <th>Study Population</th>
      <th>Calculator</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><strong>Creatinine only</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Schwartz equation (k=0.55)<a class="citation" href="#schwartz1976a"><span style="vertical-align: super">8</span></a>
</td>
      <td>Children 1–21 with <abbr title="chronic kidney disease">CKD</abbr>
</td>
      <td>—</td>
    </tr>
    <tr>
      <td>Modified bedside Schwartz eq. (k=0.413)<a class="citation" href="#schwartz2009b"><span style="vertical-align: super">9</span></a>
</td>
      <td>Children 2–18 with <abbr title="chronic kidney disease">CKD</abbr>
</td>
      <td><a href="https://www.kidney.org/professionals/kdoqi/gfr_calculatorPed">Link to modified Schwartz calculator</a></td>
    </tr>
    <tr>
      <td><strong>Cystatin C only</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>Zappitelli equation<a class="citation" href="#zappitelli2006a"><span style="vertical-align: super">6</span></a>
</td>
      <td>Children 1–18 with <abbr title="chronic kidney disease">CKD</abbr> or kidney transplant</td>
      <td>—</td>
    </tr>
    <tr>
      <td><strong>Creatinine, Cystatin C, or combined</strong></td>
      <td> </td>
      <td> </td>
    </tr>
    <tr>
      <td>CKiD U25 equation<a class="citation" href="#pierce2021a"><span style="vertical-align: super">7</span></a>
</td>
      <td>Children 1–25 with <abbr title="chronic kidney disease">CKD</abbr>
</td>
      <td><a href="https://qxmd.com/calculate/calculator_822/ckid-u25-egfr-calculator">Link to CKiD U25 calculator</a></td>
    </tr>
    <tr>
      <td>
<abbr title="chronic kidney disease">CKD</abbr>-Epi equation<a class="citation" href="#inker2021a"><span style="vertical-align: super">10</span></a>
</td>
      <td>Adults ≥18 with and without <abbr title="chronic kidney disease">CKD</abbr>
</td>
      <td><a href="https://www.kidney.org/professionals/KDOQI/gfr_calculator">Link to <abbr title="chronic kidney disease">CKD</abbr>-Epi calculator</a></td>
    </tr>
  </tbody>
</table>

<h4 class="key-points-head" id="clinical-pearl">
<a class="anchor" href="#clinical-pearl" aria-hidden="true"><span class="octicon octicon-link"></span></a>Clinical Pearl</h4>

<ul class="key-points-list">
  <li>In children with spina bifida, Cystatin C has been shown to be a better serum marker of <abbr title="estimated glomerular filtration rate">eGFR</abbr> compared to creatinine. Consider sending serum Cystatin C, if able, at least annually on children with spina bifida after the age of 2 years to monitor their kidney function and refer to a pediatric nephrologist if the <abbr title="estimated glomerular filtration rate">eGFR</abbr> is abnormal.<a class="citation" href="#dangle2017a"><span style="vertical-align: super">4</span></a>
</li>
</ul>

<h3 id="assessment-of-tubular-function">
<a class="anchor" href="#assessment-of-tubular-function" aria-hidden="true"><span class="octicon octicon-link"></span></a>Assessment of Tubular Function</h3>

<p>Tubular function can be assessed via electrolyte balance as well as the ability to concentrate and dilute urine. Tubulopathies can often be successfully diagnosed via interpretation of electrolyte abnormalities.<a class="citation" href="#ariceta2006a"><span style="vertical-align: super">11</span></a> For example, tubular wasting of sodium, phosphorus, potassium, amino acids and glucose should precipitate an evaluation for Fanconi syndrome. Fanconi syndrome occurs when there is a global defect in proximal tubular function with resultant urinary losses of the filtered load that would normally be reabsorbed.<a class="citation" href="#fanconi1961a"><span style="vertical-align: super">12</span></a> Children with Fanconi syndrome typically present with failure to thrive.</p>

<p>As stated previously, urinary concentration occurs in the collecting ducts in the presence of, and renal response to anti-diuretic hormone (<abbr title="antidiuretic hormone">ADH</abbr>). The concentration gradient that allows for concentrating the urine is set up in the loop of Henle, which first dilutes urine. Urine can be diluted to ~50 mOsm/kg and concentrated to ~1200 mOsm/kg. Full concentrating ability takes several months to develop, and a typical full-term neonate can only concentrate their urine to ~500 mOsm/kg. This concentrating defect of infancy is a result of an immature counter current multiplier as well as relative tissue insensitivity to <abbr title="antidiuretic hormone">ADH</abbr>.<a class="citation" href="#gardner-a"><span style="vertical-align: super">13</span></a></p>

<h3 class="key-points-head" id="clinical-pearl-1">
<a class="anchor" href="#clinical-pearl-1" aria-hidden="true"><span class="octicon octicon-link"></span></a>Clinical Pearl</h3>

<ul class="key-points-list">
  <li>To estimate urine osmolality (Uosm), multiply the last two digits of the urine specific gravity by 30.</li>
  <li>Example: Urine specific gravity of 1.0<strong class="text-decoration-underline">20</strong>
</li>
  <li>Estimated Uosm = 20 × 30 = 600 mOsm/kg</li>
</ul>

<p>In general, if serum electrolytes (sodium, potassium, phosphorus, calcium, bicarbonate) are within normal limits, the urinalysis indicates that the child can concentrate or dilute their urine, and there is no tubular wasting of glucose or amino acids/protein, then tubular function can be assessed as normal.</p>

<h4 id="tubular-function-by-age">
<a class="anchor" href="#tubular-function-by-age" aria-hidden="true"><span class="octicon octicon-link"></span></a>Tubular Function by Age</h4>

<p>Like <abbr title="glomerular filtration rate">GFR</abbr>, tubular function takes time to mature—this also coincides with the increasing <abbr title="glomerular filtration rate">GFR</abbr> over the first few years of life. Typical values for urine electrolytes and serum electrolytes change over time, with some tubular function taking years to reach full maturity. The ability to concentrate the urine takes nearly a year to mature, making infants at greater risk for dehydration. Water excretion also takes time to mature, making it very important to provide hypotonic fluids to infants (i.e., breastmilk or formula) and not free water to prevent hyponatremia. Sodium reabsorption is initially poor in newborns, making the <abbr title="fractional excretion of sodium">FENa</abbr> higher in newborns if assessing for pre-renal acute kidney injury. Additionally, serum potassium levels are higher in newborns due to poor distal tubular secretion of potassium, which matures over the first 2 weeks of life. Serum bicarbonate levels are also lower in the newborn period due to poor reabsorption of bicarbonate in the proximal tubule and increased overall acid production in infants. Lastly, urine calcium excretion in increase in infants and slowly decreases until 10 years of age, making normal urine calcium/creatinine ratios decrease as the children get older.</p>

<h4 class="key-points-head" id="clinical-pearl-2">
<a class="anchor" href="#clinical-pearl-2" aria-hidden="true"><span class="octicon octicon-link"></span></a>Clinical Pearl</h4>

<ul class="key-points-list">
  <li>Many children with <abbr title="chronic kidney disease">CKD</abbr> due to congenital anomalies of the kidney and urinary tract (<abbr title="congenital anomalies of the kidney and urinary tract">CAKUT</abbr>) may never fully be able to concentrate their urine, meaning that they still may have brisk urine output when clinically dehydrated. Be sure to assess patients with underlying kidney disease for other signs/symptoms of dehydration other than relying on urine output. Have a low threshold to provide IV or oral rehydration during acute illnesses.</li>
</ul>

<h3 id="acute-kidney-injury">
<a class="anchor" href="#acute-kidney-injury" aria-hidden="true"><span class="octicon octicon-link"></span></a>Acute Kidney Injury</h3>

<p>Acute kidney injury (<abbr title="acute kidney injury">AKI</abbr>) refers to a sudden decrease in glomerular filtration rate. <abbr title="acute kidney injury">AKI</abbr> is typically reversible, however there is a growing appreciation that <abbr title="acute kidney injury">AKI</abbr> can lead to chronic kidney disease (<abbr title="chronic kidney disease">CKD</abbr>). There are several staging classifications of <abbr title="acute kidney injury">AKI</abbr>, such as the p-<abbr title="Risk, Injury, and Failure; and Loss, and End-stage kidney disease">RIFLE</abbr> criteria and <abbr title="Kidney Disease Improving Global Outcomes">KDIGO</abbr> criteria, which stratifies <abbr title="acute kidney injury">AKI</abbr> in children.<a class="citation" href="#sutherland2015a"><span style="vertical-align: super">14</span></a> The <abbr title="Kidney Disease Improving Global Outcomes">KDIGO</abbr> criteria has been adopted as the more common way of assessing <abbr title="acute kidney injury">AKI</abbr> in the literature in recent years. It classifies <abbr title="acute kidney injury">AKI</abbr> into stage 1, 2, and 3 based on rise of serum creatinine or decrease in urine output.<a class="citation" href="#kdigokakiw2012a"><span style="vertical-align: super">15</span></a> Even more recently, there are propositions to adapt a modified <abbr title="Kidney Disease Improving Global Outcomes">KDIGO</abbr> criteria to neonatal <abbr title="acute kidney injury">AKI</abbr>.<a class="citation" href="#selewski2015a"><span style="vertical-align: super">16</span></a></p>

<p><strong id="table-2" class="table-number">Table 2</strong> <abbr title="Kidney Disease Improving Global Outcomes">KDIGO</abbr> classification of <abbr title="acute kidney injury">AKI</abbr> in children using either serum creatinine or urine output.<a class="citation" href="#kdigokakiw2012a"><span style="vertical-align: super">15</span></a></p>

<table>
  <thead>
    <tr>
      <th>
<abbr title="acute kidney injury">AKI</abbr> Stage</th>
      <th>Serum creatinine</th>
      <th>Urine output</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Stage 1</td>
      <td>1.5–1.9× baseline or ≥ 0.3 mg/dL (≥ 26.5 umol/L) increase</td>
      <td>&lt; 0.5 mL/kg/hr for 6–12 hrs</td>
    </tr>
    <tr>
      <td>Stage 2</td>
      <td>2.0–2.9× baseline</td>
      <td>&lt; 0.5 mL/kg/hr ≥12 hrs</td>
    </tr>
    <tr>
      <td>Stage 3</td>
      <td>3.0× baseline or increase in sCr to ≥ 4.0 mg/dL (≥ 353.6 umol/L) or initiation of <abbr title="renal replacement therapy">RRT</abbr>
</td>
      <td>&lt; 0.3 mL/kg/hr for ≥24 hrs or anuria for ≥ 12 hours</td>
    </tr>
  </tbody>
</table>

<p>In the setting of <abbr title="acute kidney injury">AKI</abbr>, it is important to understand that a rise in creatinine typically appears only after significant renal dysfunction has begun, and often several days following the initial insult - well into the process of kidney injury. There are now different <abbr title="acute kidney injury">AKI</abbr> biomarkers being studied and implemented into clinical practice to detect <abbr title="acute kidney injury">AKI</abbr> earlier in the process before the creatinine rise.<a class="citation" href="#sandokji2020a"><span style="vertical-align: super">17</span></a> Neutrophil gelatinase associated lipoprotein (<abbr title="neutrophil gelatinase associated lipoprotein">NGAL</abbr>) has been the most promising marker of early <abbr title="acute kidney injury">AKI</abbr> so far and is starting to be offered as a clinical test in some hospitals. Practice patterns involving <abbr title="neutrophil gelatinase associated lipoprotein">NGAL</abbr> vary, but it is often used to detect <abbr title="acute kidney injury">AKI</abbr> prior to changes in serum creatinine or urine output, especially in the critical care setting.<a class="citation" href="#stanski2019a"><span style="vertical-align: super">18</span></a></p>

<h4 id="etiology-of-aki">
<a class="anchor" href="#etiology-of-aki" aria-hidden="true"><span class="octicon octicon-link"></span></a>Etiology of <abbr title="acute kidney injury">AKI</abbr>
</h4>

<p>A typical starting point to determine the etiology of <abbr title="acute kidney injury">AKI</abbr> includes an assessment of prerenal, intrinsic renal, or obstructive processes. <em class="text-decoration-underline">Obstruction</em> can be ruled out via imaging, typically via renal and bladder ultrasound. Prerenal and intrinsic etiologies of kidney injury will be discussed herein.</p>

<h5 id="prerenal-azotemia">
<a class="anchor" href="#prerenal-azotemia" aria-hidden="true"><span class="octicon octicon-link"></span></a>Prerenal Azotemia</h5>

<p><strong>Prerenal azotemia</strong> refers to a decrease in <abbr title="glomerular filtration rate">GFR</abbr> secondary to poor renal perfusion, often in the setting dehydration or volume loss. Patients who are prerenal will often exhibit oliguria (urine output &lt;0.5 mL/kg/hr in children, &lt;500 mL/day in adults) and will demonstrate signs and symptoms of dehydration (tachycardia, dry mucus membranes, hypotension, increased skin turgor). Assessment of a urinary fractional excretion of sodium (<abbr title="fractional excretion of sodium">FENa</abbr>) will be very low (&lt;1%) (<a href="#table-3" class="table-link">Table 3</a>), indicating that the renal tubules are appropriately reabsorbing sodium. Blood urea nitrogen (BUN) is usually elevated in prerenal azotemia. This is a result of an increase in reabsorption of sodium in the proximal tubule which results in a passive reabsorption of both water and urea nitrogen. Thus, the patient’s serum BUN to creatinine ratio will be elevated in prerenal azotemia. The treatment of prerenal azotemia is intravascular volume repletion, typically via normal saline boluses. After attaining euvolemia, it is important not to continue to bolus with excessive fluids, as prerenal azotemia can lead to acute tubular necrosis (see below) if the injury is long-standing, and in such cases, the patient may not be able to make urine. In this case, excessive fluid resuscitation can lead to hypervolemia with resultant hypertension, edema, and respiratory distress.</p>

<h5 id="intrinsic-renal-failure">
<a class="anchor" href="#intrinsic-renal-failure" aria-hidden="true"><span class="octicon octicon-link"></span></a>Intrinsic Renal Failure</h5>

<p><strong>Intrinsic renal failure</strong> refers to <abbr title="acute kidney injury">AKI</abbr> that is not secondary to prerenal or obstructive causes. It is most helpful to refer to the construct of the nephron when considering intrinsic <abbr title="acute kidney injury">AKI</abbr> as this correlates with the various etiologies: 1) vascular causes; 2) glomerulonephritis; 3) acute tubular necrosis; and 4) acute interstitial nephritis.</p>

<h5 id="vascular">
<a class="anchor" href="#vascular" aria-hidden="true"><span class="octicon octicon-link"></span></a>Vascular</h5>

<p>Vascular causes of <abbr title="acute kidney injury">AKI</abbr> are quite common and include any perturbation in blood flow to the kidney—most commonly secondary to medications such as <abbr title="non-steroidal antiinflammatories">NSAIDs</abbr> or cyclosporine/tacrolimus, which cause vasoconstriction of the afferent arterioles, or <abbr title="angiotensin converting enzyme">ACE</abbr>-inhibitors/<abbr title="angiotensin receptor blockers">ARBs</abbr> such as lisinopril, which cause vasodilation of the efferent arterioles.<a class="citation" href="#goldstein2013a"><span style="vertical-align: super">19</span></a> For this reason, it is critical to remember that <abbr title="non-steroidal antiinflammatories">NSAIDs</abbr>, including ketorolac and ibuprofen are completely contraindicated in any patient who is dehydrated, see <a href="#figure-3" class="figure-link">Figure 3</a>.<a class="citation" href="#musu2011a"><span style="vertical-align: super">20</span></a> Thrombotic microangiopathies (<abbr title="thrombotic microangiopathy">TMA</abbr>) such as the hemolytic uremic syndrome can also be classified as a vascular cause of <abbr title="acute kidney injury">AKI</abbr>. In <abbr title="thrombotic microangiopathy">TMA</abbr>, platelet rich thrombi form in the capillary loops of the glomeruli, restricting blood flow and leading to a decrease in <abbr title="glomerular filtration rate">GFR</abbr>.</p>

<p><img src="https://pediatricurologybook.com/assets/figures/figure-03-3.svg" alt="Figure 3" class="float-start img-fluid"><br>
<strong id="figure-3" class="figure-number">Figure 3</strong> Mechanism of acute kidney injury in the setting of dehydration with <abbr title="non-steroidal antiinflammatory">NSAID</abbr> exposure. (A) normal autoregulation in the setting of dehydration where decreased effective circulating volume leads to vasodilation of the afferent arterioles via prostaglandins, while the efferent arterioles are constricted by angiotensin II (via the renin-aldosterone-angiotensin system). (B) Impairment of autoregulation by <abbr title="non-steroidal antiinflammatories">NSAIDs</abbr>.</p>

<h5 id="glomerulonephritis">
<a class="anchor" href="#glomerulonephritis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Glomerulonephritis</h5>

<p>Glomerulonephritis (<abbr title="glomerulonephritis">GN</abbr>) can typically be diagnosed quite readily with evaluation of the urine sediment showing red blood cell casts. The hallmarks of acute glomerulonephritis include hypertension, edema and <abbr title="acute kidney injury">AKI</abbr>. The differential diagnosis of glomerulonephritis can be divided into two main categories based on serum complement levels—hypocomplementemic or normocomplementemic. Hypocomplementic <abbr title="glomerulonephritides">GNs</abbr> include post-infectious <abbr title="glomerulonephritis">GN</abbr>, systemic lupus erythematosis, and membranoproliferative <abbr title="glomerulonephritis">GN</abbr>. Normocomplementemic <abbr title="glomerulonephritides">GNs</abbr> include IgA nephropathy, Alport’s syndrome, and the ANCA vasculitides. Treatment of acute <abbr title="glomerulonephritis">GN</abbr> depends on the underlying cause, other than in the self-resolving illness of post-infectious <abbr title="glomerulonephritis">GN</abbr>, most <abbr title="glomerulonephritides">GNs</abbr> require treatment with immunosuppressive therapy.</p>

<h5 id="acute-tubular-necrosis">
<a class="anchor" href="#acute-tubular-necrosis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Acute Tubular Necrosis</h5>

<p><strong>Acute tubular necrosis (<abbr title="acute tubular necrosis">ATN</abbr>)</strong> is the most common cause of <abbr title="acute kidney injury">AKI</abbr>. <abbr title="acute tubular necrosis">ATN</abbr> is usually caused either by ischemia-reperfusion injury, or exposure to nephrotoxic medications. Patients with <abbr title="acute tubular necrosis">ATN</abbr> are typically oliguric and their urine sediment may demonstrate muddy brown or granular casts. In contrast to prerenal azotemia, patients with <abbr title="acute tubular necrosis">ATN</abbr> have a <abbr title="fractional excretion of sodium">FENa</abbr> &gt;1% (<a href="#table-3" class="table-link">Table 3</a>).</p>

<p><strong id="table-3" class="table-number">Table 3</strong> Comparison of prerenal azotemia to acute tubular necrosis (<abbr title="acute tubular necrosis">ATN</abbr>).</p>

<table>
  <thead>
    <tr>
      <th> </th>
      <th>Prerenal Azotemia</th>
      <th><abbr title="acute tubular necrosis">ATN</abbr></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Urine volume</td>
      <td>↑</td>
      <td>usually ↓</td>
    </tr>
    <tr>
      <td>BUN/creatinine</td>
      <td>&gt;20/1</td>
      <td>~10/1</td>
    </tr>
    <tr>
      <td>Urine [Na*)</td>
      <td>&lt;20 mEg/L</td>
      <td>&gt;40 mEg/L</td>
    </tr>
    <tr>
      <td><abbr title="fractional excretion of sodium">FENa</abbr></td>
      <td>&lt;1%</td>
      <td>&gt;2%</td>
    </tr>
    <tr>
      <td>Urine osm</td>
      <td>&gt;500 mOsm/kg</td>
      <td>~300 mOsm/kg</td>
    </tr>
    <tr>
      <td>Urine sediment</td>
      <td>hyaline or granular casts</td>
      <td>brown casts, renal tubular cell casts</td>
    </tr>
    <tr>
      <td>Course</td>
      <td>reversible with correction of underlying cause</td>
      <td>oliguria x days, gradual recovery over days to wks</td>
    </tr>
  </tbody>
</table>

<p>Treatment of <abbr title="acute tubular necrosis">ATN</abbr> includes renal rest—maintaining euvolemia and avoidance of nephrotoxic medications. Some studies have shown the use of theophylline helps reduce <abbr title="acute kidney injury">AKI</abbr>/<abbr title="acute tubular necrosis">ATN</abbr> in neonates caused by perinatal asphyxia, but decision to administer this drug should be done in collaboration with a pediatric nephrologist.<a class="citation" href="#bellos2021a"><span style="vertical-align: super">21</span></a> In oliguric patients, strict attention to fluid balance is necessary to maintain euvolemia. Recovery from <abbr title="acute tubular necrosis">ATN</abbr> may take days to weeks, and often the oliguria transitions to polyuria with a persistently elevated serum creatinine. When the patient becomes polyuric, it is critical to maintain adequate hydration. Until the renal tubules recover, the patient is unlikely to be able to concentrate their urine, and as such they are at risk for developing prerenal azotemia with a potential secondary renal hit if intake is not increased to keep up with output.</p>

<h5 class="key-points-head" id="clinical-pearl-3">
<a class="anchor" href="#clinical-pearl-3" aria-hidden="true"><span class="octicon octicon-link"></span></a>Clinical Pearl</h5>

<ul class="key-points-list">
  <li>A good rule of thumb when dealing with such patients is to obtain daily weights, strict ins and outs and to maintain the euvolemic patient on 1/3 × their maintenance fluid plus 1:1 replacement of urine output. The 1/3 × maintenance approximates the patient’s insensible fluid losses, while the replacement of urine output will work to maintain euvolemia in both oliguric and polyuric patients.</li>
  <li>In patients who are <abbr title="nil per os">NPO</abbr>, typical fluids can be 5% dextrose 0.9% normal saline if they are otherwise normal children without underlying kidney dysfunction.<a class="citation" href="#feld2018a"><span style="vertical-align: super">22</span></a> However, serum electrolytes should be followed closely while on IV fluids. Polyuric patients may need addition of potassium to their intravenous fluids. Patients who have loose stools may need additional repletion for stool losses, including the addition of bicarbonate to the fluids. Children with kidney dysfunction should be considered case by case but starting fluids containing 5% dextrose 0.45% normal saline to reduce their salt load should be considered.</li>
</ul>

<h5 id="acute-interstitial-nephritis">
<a class="anchor" href="#acute-interstitial-nephritis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Acute Interstitial Nephritis</h5>

<p><strong>Acute interstitial nephritis (<abbr title="acute interstitial nephritis">AIN</abbr>)</strong> is an underappreciated cause of <abbr title="acute kidney injury">AKI</abbr>. <abbr title="acute interstitial nephritis">AIN</abbr> is often triggered by a reaction to an offending medication and is sometimes referred to as allergic interstitial nephritis. <abbr title="acute interstitial nephritis">AIN</abbr> may also be triggered by a viral infection; however most causes of <abbr title="acute interstitial nephritis">AIN</abbr> are idiopathic. While historically, urine was often sent for evaluation of eosinophils, eosinophiluria is neither sensitive nor specific for diagnosing <abbr title="acute interstitial nephritis">AIN</abbr>. As such, <abbr title="acute interstitial nephritis">AIN</abbr> can be diagnosed clinically in the setting of a patient with non-oliguric <abbr title="acute kidney injury">AKI</abbr> with a bland urine sediment. Treatment of <abbr title="acute interstitial nephritis">AIN</abbr> includes cessation of the offending medication when clinically possible. <abbr title="acute interstitial nephritis">AIN</abbr> can also be treated with steroids, however, if the cause is medication-related, kidney injury may return once the steroids are discontinued. A rare but associated disease is tubulointerstitial nephritis and uveitis (<abbr title="tubulointerstitial nephritis and uveitis">TINU</abbr>) syndrome.<a class="citation" href="#yitzhaki2000a"><span style="vertical-align: super">23</span></a> These patients have both <abbr title="acute interstitial nephritis">AIN</abbr> and uveitis. <abbr title="tubulointerstitial nephritis and uveitis">TINU</abbr> is often responsive to steroids, however, the uveitis requires ophthalmologic evaluation and treatment separate and in addition to renal evaluation and treatment.<a class="citation" href="#chevalier2021a"><span style="vertical-align: super">24</span></a></p>

<h5 class="key-points-head" id="clinical-pearl-4">
<a class="anchor" href="#clinical-pearl-4" aria-hidden="true"><span class="octicon octicon-link"></span></a>Clinical Pearl</h5>

<ul class="key-points-list">
  <li>Patients with an intra-abdominal urinary leak can inappropriately be diagnosed with <abbr title="acute kidney injury">AKI</abbr>. In these patients, their serum creatinine rises secondary to reabsorption of urine creatinine across the peritoneal membrane with a resultant rise in serum creatinine. In this case, serum creatinine no longer reflects renal filtration. The diagnosis should be suspected in any patient with new development of ascites in the setting of a rising creatinine, who is at risk for urinary leak (i.e. recent surgical procedure).</li>
</ul>

<h5 id="indications-for-dialysis">
<a class="anchor" href="#indications-for-dialysis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Indications for Dialysis</h5>
<p>There is no current treatment for <abbr title="acute kidney injury">AKI</abbr> other than supportive care. Renal replacement therapy may be required if optimal medical management does not suffice. Indications for initiating acute dialysis include volume overload, electrolyte derangements, metabolic acidosis or uremia.</p>

<h3 id="chronic-kidney-disease">
<a class="anchor" href="#chronic-kidney-disease" aria-hidden="true"><span class="octicon octicon-link"></span></a>Chronic Kidney Disease</h3>

<p>Chronic kidney disease (<abbr title="chronic kidney disease">CKD</abbr>) refers to either laboratory or radiographic evidence of kidney disease that progresses beyond 3 months. There are five stages of <abbr title="chronic kidney disease">CKD</abbr>, based on estimated glomerular filtration rate (<a href="#figure-4" class="figure-link">Figure 4</a>). In children with <abbr title="chronic kidney disease">CKD</abbr>, specific equations (noted above) are used to estimate their <abbr title="estimated glomerular filtration rate">eGFR</abbr> in order to stage the degree of <abbr title="chronic kidney disease">CKD</abbr>. Unlike adult patients who are often followed by their primary care provider throughout the early stages of <abbr title="chronic kidney disease">CKD</abbr>, all children with <abbr title="chronic kidney disease">CKD</abbr> should be followed by a pediatric nephrologist for subspecialty care.<a class="citation" href="#lamb2013a"><span style="vertical-align: super">25</span></a> Particular attention is paid to the growth and development of children with <abbr title="chronic kidney disease">CKD</abbr>. The frequency of nephrology follow-up correlates with the stage of <abbr title="chronic kidney disease">CKD</abbr>. Of note, <abbr title="glomerular filtration rate">GFR</abbr> reaches its max at around 2 years of age, making it impossible to stage <abbr title="chronic kidney disease">CKD</abbr> in children less than 2 years of age accurately.</p>

<p><img src="https://pediatricurologybook.com/assets/figures/figure-03-4.svg" alt="Figure 4" class="float-start img-fluid"><br>
<strong id="figure-4" class="figure-number">Figure 4</strong> Stages of Chronic Kidney Disease.</p>

<h4 id="management-of-chronic-kidney-disease">
<a class="anchor" href="#management-of-chronic-kidney-disease" aria-hidden="true"><span class="octicon octicon-link"></span></a>Management of Chronic Kidney Disease</h4>

<p>Unfortunately, there is no cure for <abbr title="chronic kidney disease">CKD</abbr>. However, early referral to a pediatric nephrologist can help with management of co-morbidities and delay progression of disease. Routine <abbr title="chronic kidney disease">CKD</abbr> management includes assessment of staging, blood pressure control, as well as monitoring for anemia, growth delay, and metabolic bone disease.</p>

<h5 id="blood-pressure-control">
<a class="anchor" href="#blood-pressure-control" aria-hidden="true"><span class="octicon octicon-link"></span></a>Blood Pressure Control</h5>

<p>Tight blood control to the 50th% for age, sex and percentile height has been shown to delay progression of <abbr title="chronic kidney disease">CKD</abbr>.<a class="citation" href="#group2009a"><span style="vertical-align: super">26</span></a> <abbr title="angiotensin converting enzyme">ACE</abbr>-inhibitors and <abbr title="angiotensin receptor blockers">ARBs</abbr> are often the preferred agent to control blood pressure as they also protect against glomerular hyperfiltration. Blood pressure should be measured at all clinic visits, preferable manually, in patients with or at risk for <abbr title="chronic kidney disease">CKD</abbr>. Referral to a pediatric nephrologist for further evaluation and possibly a 24 hour ambulatory blood pressure monitor study should be made for any abnormal clinic blood pressure in a child with <abbr title="chronic kidney disease">CKD</abbr>.</p>

<h5 id="anemia-of-chronic-kidney-disease">
<a class="anchor" href="#anemia-of-chronic-kidney-disease" aria-hidden="true"><span class="octicon octicon-link"></span></a>Anemia of Chronic Kidney Disease</h5>

<p>Children with <abbr title="chronic kidney disease">CKD</abbr> have several reasons to be anemic—including erythropoietin deficiency and increased hepcidin levels which leads to poor utilization of iron stores.<a class="citation" href="#atkinson2015a"><span style="vertical-align: super">27</span></a> Patients with <abbr title="chronic kidney disease">CKD</abbr> should have routine CBCs to monitor for the development of anemia. If and when they become anemic, iron stores should be checked and normalized. Patients who remain anemic despite adequate iron stores should be started on erythropoiesis stimulating agents such as epoetin alfa or darbepoetin alfa.<a class="citation" href="#lamb2013a"><span style="vertical-align: super">25</span></a></p>

<h5 id="metabolic-bone-disease">
<a class="anchor" href="#metabolic-bone-disease" aria-hidden="true"><span class="octicon octicon-link"></span></a>Metabolic Bone Disease</h5>

<p>Formerly referred to as secondary hyperparathyroidism, metabolic bone disease encompasses not only secondary hyperparathyroidism, but also bone mineralization and vascular calcifications. <abbr title="metabolic bone disease">MBD</abbr> is often the most challenging aspect in managing children with <abbr title="chronic kidney disease">CKD</abbr> and is unfortunately the reason for a significant amount of morbidity and mortality in our pediatric patients with <abbr title="chronic kidney disease">CKD</abbr>. <abbr title="metabolic bone disease">MBD</abbr> leads to increased cardiovascular disease, the leading cause of death in patients with <abbr title="chronic kidney disease">CKD</abbr>. Indeed, a pediatric patient with end stage renal disease has the cardiovascular risks of a patient in their 70s.<a class="citation" href="#mitsnefes2012a"><span style="vertical-align: super">28</span></a> Management includes maintaining adequate stores of 25-hydroxy vitamin D, maintaining normocalcemia and normal serum phosphorus levels, and supplementation of active 1-25-dihydroxyvitamin D.<a class="citation" href="#wesseling-perry2013a"><span style="vertical-align: super">29,30</span></a> It is often quite difficult for patients to comply with the prescribed phosphorus binders which are taken with meals, and often cause gagging and discomfort. This is particularly difficult in young children, with whom mealtime can already be quite challenging.</p>

<h5 id="growth">
<a class="anchor" href="#growth" aria-hidden="true"><span class="octicon octicon-link"></span></a>Growth</h5>

<p>Children with <abbr title="chronic kidney disease">CKD</abbr> often have difficulty with growth and development. A multidisciplinary team including a renal dietician is critical for proper monitoring of nutritional intake and growth. Unlike adults with <abbr title="chronic kidney disease">CKD</abbr>, children do not have a reduced protein limit, as they require protein for growth. We therefore recommend children with <abbr title="chronic kidney disease">CKD</abbr> obtain the recommended daily allowance of protein. Linear growth is particularly challenging because of a relative tissue insensitivity to growth hormone. Infants and toddlers with <abbr title="chronic kidney disease">CKD</abbr> often require gastrostomy tubes for either medication administration and/or supplemental formula feeds. Special renal formulas that support growth and nutrition while limiting potassium and phosphorus are often required. Supplemental growth hormone is indicated in patients not growing well linearly despite adequate caloric intake. Unfortunately, many families decline growth hormone treatment in order to save their child a daily injection, however quality of life studies have demonstrated that adult height positively correlates with quality of life.<a class="citation" href="#goldstein2007a"><span style="vertical-align: super">31</span></a></p>

<h5 id="renal-replacement-therapy">
<a class="anchor" href="#renal-replacement-therapy" aria-hidden="true"><span class="octicon octicon-link"></span></a>Renal Replacement Therapy</h5>

<p>Children who are progressing to stage V <abbr title="chronic kidney disease">CKD</abbr> require evaluation for renal replacement therapy. <abbr title="renal replacement therapy">RRT</abbr> can be in the form of either peritoneal dialysis (<abbr title="peritoneal dialysis">PD</abbr>), hemodialysis (<abbr title="hemodialysis">HD</abbr>), or kidney transplantation. For patients who have a potential living donor, preemptive transplantation may be a suitable and often desirable option. Evaluation of a living donor make take several months, so such a preemptive transplantation should begin while the patient is still in stage IV <abbr title="chronic kidney disease">CKD</abbr>, if possible. Similarly, introducing the concepts of dialysis and transplantation at an earlier stage, such as stage III often benefits the family and patient so they can begin to think about dialysis modalities versus preemptive transplantation.</p>

<p>The term ‘dialysis’ refers to two separate mechanisms: 1) diffusion of solutes across a semipermeable membrane, and 2) removal of fluid via ultrafiltration.</p>

<h5 id="peritoneal-dialysis">
<a class="anchor" href="#peritoneal-dialysis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Peritoneal Dialysis</h5>

<p>In peritoneal dialysis, dialysate is placed in the peritoneal cavity. The peritoneal membrane acts as the semipermeable membrane and allows solutes to flow across and down their concentration gradient. Ultrafiltration is controlled via the addition of dextrose to the dialysate fluid. By increasing the dextrose concentration to the dialysate, the osmotic gradient increases, thereby pulling more fluid from the patient into the peritoneal cavity. The fluid is then drained from the peritoneum. Most pediatric patients undergo home <abbr title="peritoneal dialysis">PD</abbr> at night while they are asleep. In this way, they undergo several cycles, typically anywhere from 6–12 cycles. The <abbr title="peritoneal dialysis">PD</abbr> prescription therefore includes the fill volume, dwell time, and dialysate to be used (including the dextrose concentration). The additional volume that is drained during each cycle drain is tallied and the total accumulated over the treatment is referred to as the ultrafiltrate (<abbr title="ultrafiltration">UF</abbr>) volume. Of note, patients may retain fluid during <abbr title="peritoneal dialysis">PD</abbr> and this typically indicates they might have been hypovolemic at the initiation of the treatment. Home <abbr title="peritoneal dialysis">PD</abbr> requires extensive training of the caregivers with frequent communication with their nephrology center. Caregivers are expected to keep daily logs of pre- and post- treatment weights, blood pressures, dialysate used and <abbr title="ultrafiltration">UF</abbr> obtained. Many patients have a sliding scale prescription such that the dextrose concentration can be adjusted based on their pre-dialysis weight and blood pressure.<a class="citation" href="#warady2020a"><span style="vertical-align: super">32</span></a></p>

<p>Peritonitis is the main risk in patients who undergo <abbr title="peritoneal dialysis">PD</abbr>. Caregivers are taught to recognize the signs and symptoms of peritonitis and are also trained to obtain a peritoneal effluent for cell count and culture prior to initiating intraperitoneal antibiotics. <abbr title="peritoneal dialysis">PD</abbr> patients on antibiotics should always receive anti-fungal prophylaxis to prevent fungal peritonitis. Fungal peritonitis is both difficult to diagnosis as well as treat, and unfortunately requires removal of the <abbr title="peritoneal dialysis">PD</abbr> catheter and has a high risk of scarring the peritoneal membrane.</p>

<p>Membrane failure can result from fungal peritonitis, recurrent bacterial peritonitis, or may be a result of glycosylation of the membrane from prolonged exposure to the dextrose in the dialysate. Routine peritoneal membrane tests are performed by their nephrologist to assess membrane characteristics and to help adjust <abbr title="peritoneal dialysis">PD</abbr> orders over time.</p>

<h5 id="hemodialysis">
<a class="anchor" href="#hemodialysis" aria-hidden="true"><span class="octicon octicon-link"></span></a>Hemodialysis</h5>

<p>In hemodialysis, the patient’s blood is circulated thru a dialysis machine containing an <abbr title="hemodialysis">HD</abbr> filter. Most filters are now hollow-fiber capillary membranes. Each fiber is hollow and allows blood to flow thru the tube, in countercurrent to dialysate flowing around the fibers. This design allows for a large surface area where-in the fibers are the semi-permeable membrane that allow for flow of solutes across the membrane and down their concentration gradient. <abbr title="ultrafiltration">UF</abbr> is attained via negative pressure applied by the dialysis machine. The <abbr title="ultrafiltration">UF</abbr> rate is limited by patient size, blood pressure and symptoms. Dialysis access can be challenging in pediatric patients. Often, fistula access is limited by patient size and vasculature. As a result, many pediatric patients have the additional risk of central line access, known to have an increased risk of infection above fistulas and grafts.<a class="citation" href="#lamb2013a"><span style="vertical-align: super">25</span></a></p>

<p>The choice of dialysis modality is made based on a combination of the child’s current medical status, underlying disease, family support and often, geographic location (i.e. distance from a hemodialysis center that will treat children). Past episodes of peritonitis or surgical procedures that have left adhesions may limit the option to pursue peritoneal dialysis. Certainly, peritoneal dialysis requires more social stability as well as time, energy and commitment from the child’s caregivers. Despite these additional responsibilities, <abbr title="peritoneal dialysis">PD</abbr> is often a preferred choice as it allows the child to continue to go to school. Alternatively, hemodialysis (<abbr title="hemodialysis">HD</abbr>) is a good alternative for patients who have either failed <abbr title="peritoneal dialysis">PD</abbr>, or who’s family may be unable to provide <abbr title="peritoneal dialysis">PD</abbr> at home. Home hemodialysis is also an option offered by some pediatric dialysis program for families who would be equipped for <abbr title="peritoneal dialysis">PD</abbr> at home, but the patient is not a suitable <abbr title="peritoneal dialysis">PD</abbr> candidate.</p>

<p>Regardless of the dialysis modality chosen, the goal of every pediatric nephrology program is to successfully transplant their pediatric patients with <abbr title="end stage renal disease">ESRD</abbr>. The life expectancy of children with <abbr title="end stage renal disease">ESRD</abbr> on dialysis is 50 years shorter than healthy age-matched cohorts, compared to 15 years shorter following transplantation.<a class="citation" href="#mitsnefes2012a"><span style="vertical-align: super">28</span></a> Transplantation evaluation includes psychosocial evaluation and at times, transplantation is delayed or put on hold if the child is not interested or is deemed to be a poor candidate based on non-compliance with prescribed therapies.</p>

<h2 class="suggested-readings-head" id="suggested-readings">
<a class="anchor" href="#suggested-readings" aria-hidden="true"><span class="octicon octicon-link"></span></a>Suggested Readings</h2>

<ol class="suggested-readings-list">
  <li><span id="atkinson2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Atkinson MA, Ng DK, Warady BA, Furth SL, Flynn JT</b></span>. <span style="font-variant: normal">The CKiD study: overview and summary of findings related to kidney disease progression</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2021; <b>36</b> (3)</span>: <span style="text-decoration: none">527–538</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-019-04458-6</span></span>.</span></span></li>
  <li><span id="schwartz2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Schwartz GJ, Work DF</b></span>. <span style="font-variant: normal">Measurement and Estimation of <abbr title="glomerular filtration rate">GFR</abbr> in Children and Adolescents</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Clin J Am Soc Nephrol</i></span> <span style="text-decoration: none">2009; <b>4</b> (11)</span>: <span style="text-decoration: none">1832–1843</span>. <span style="text-decoration: underline">DOI: 10.2215/cjn.01640309</span></span>.</span></span></li>
  <li><span id="zeidel2014a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Zeidel ML, Hoenig MP</b></span>. <span style="font-variant: normal">Cardiac Physiology for the Clinician</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Jama</i></span> <span style="text-decoration: none">2014; <b>235</b> (26)</span>: <span style="text-decoration: none">2865</span>. <span style="text-decoration: underline">DOI: 10.1001/jama.1976.03260520057032</span></span>.</span></span></li>
</ol>

<h2 id="references">
<a class="anchor" href="#references" aria-hidden="true"><span class="octicon octicon-link"></span></a>References</h2>

<ol class="bibliography">
<li>
<span id="schwartz2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Schwartz GJ, Work DF</b></span>. <span style="font-variant: normal">Measurement and Estimation of GFR in Children and Adolescents</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Clin J Am Soc Nephrol</i></span> <span style="text-decoration: none">2009; <b>4</b> (11)</span>: <span style="text-decoration: none">1832–1843</span>. <span style="text-decoration: underline">DOI: 10.2215/cjn.01640309</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19820136/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.2215/cjn.01640309" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="schwartz2007a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Schwartz GJ, Furth SL</b></span>. <span style="font-variant: normal">Glomerular filtration rate measurement and estimation in chronic kidney disease</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2007; <b>22</b> (11)</span>: <span style="text-decoration: none">1839–1848</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-006-0358-1</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17216261/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-006-0358-1" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="fox2014a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Fox JA, Dudley AG, Bates C, Cannon GM</b></span>. <span style="font-variant: normal">Cystatin C as a Marker of Early Renal Insufficiency in Children with Congenital Neuropathic Bladder</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2014; <b>191</b> (5s)</span>: <span style="text-decoration: none">1602–1607</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2013.09.093</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/24679869/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2013.09.093" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="dangle2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Dangle PP, Ayyash O, Kang A, Bates C, Fox J, Stephany H, <i>et al.</i></b></span>. <span style="font-variant: normal">Cystatin C-calculated Glomerular Filtration Rate–A Marker of Early Renal Dysfunction in Patients With Neuropathic Bladder</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Urology</i></span> <span style="text-decoration: none">2017; <b>100</b></span>: <span style="text-decoration: none">213–217</span>. <span style="text-decoration: underline">DOI: 10.1016/j.urology.2016.08.011</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/27542858/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.urology.2016.08.011" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="filler2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Filler G, Lee M</b></span>. <span style="font-variant: normal">Educational review: measurement of GFR in special populations</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2018; <b>33</b> (11)</span>: <span style="text-decoration: none">2037–2046</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-017-3852-8</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29218435/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-017-3852-8" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="zappitelli2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Zappitelli M, Parvex P, Joseph L, Paradis G, Grey V, Lau S, <i>et al.</i></b></span>. <span style="font-variant: normal">Derivation and Validation of Cystatin C–Based Prediction Equations for GFR in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Am J Kidney Dis</i></span> <span style="text-decoration: none">2006; <b>48</b> (2)</span>: <span style="text-decoration: none">221–230</span>. <span style="text-decoration: underline">DOI: 10.1053/j.ajkd.2006.04.085</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/16860187/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1053/j.ajkd.2006.04.085" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="pierce2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Pierce CB, Muñoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ</b></span>. <span style="font-variant: normal">Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Kidney Int</i></span> <span style="text-decoration: none">2021; <b>99</b> (4)</span>: <span style="text-decoration: none">948–956</span>. <span style="text-decoration: underline">DOI: 10.1016/j.kint.2020.10.047</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33301749/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.kint.2020.10.047" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="schwartz1976a"><span style="font-weight: normal; text-decoration: none"><span style="font-variant: normal">A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Aktuelle Urol</i></span> <span style="text-decoration: none">1976; <b>35</b> (03)</span>: <span style="text-decoration: none">195–196</span>. <span style="text-decoration: underline">DOI: 10.1055/s-2004-830943</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/951142/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1055/s-2004-830943" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="schwartz2009b"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, <i>et al.</i></b></span>. <span style="font-variant: normal">New Equations to Estimate GFR in Children with CKD</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Am Soc Nephrol</i></span> <span style="text-decoration: none">2009; <b>20</b> (3)</span>: <span style="text-decoration: none">629–637</span>. <span style="text-decoration: underline">DOI: 10.1681/asn.2008030287</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19158356/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1681/asn.2008030287" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="inker2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, <i>et al.</i></b></span>. <span style="font-variant: normal">New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>N Engl J Med</i></span> <span style="text-decoration: none">0AD; <b>385</b> (19)</span>: <span style="text-decoration: none">1737–1749</span>. <span style="text-decoration: underline">DOI: 10.1056/nejmoa2102953</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/34554658/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1056/nejmoa2102953" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="ariceta2006a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Ariceta G, Rodrı́guez-Soriano Juan</b></span>. <span style="font-variant: normal">Inherited Renal Tubulopathies Associated With Metabolic Alkalosis: Effects on Blood Pressure</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Semin Nephrol</i></span> <span style="text-decoration: none">2006; <b>26</b> (6)</span>: <span style="text-decoration: none">422–433</span>. <span style="text-decoration: underline">DOI: 10.1016/j.semnephrol.2006.10.002</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17275579/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.semnephrol.2006.10.002" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="fanconi1961a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Louis-Jean S, Ching PR, Wallingford A</b></span>. <span style="font-variant: normal">Distal Renal Tubular Acidosis in Sjögren’s Syndrome: A Case Report</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Cureus</i></span> <span style="text-decoration: none">1961; <b>16</b></span>: <span style="text-decoration: none">609–621</span>. <span style="text-decoration: underline">DOI: 10.7759/cureus.10962</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/13891506/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.7759/cureus.10962" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="gardner-a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Gardner SL, Carter BS, Ensman-Hines MI, Niermeyer S</b></span>. <span style="font-variant: normal">Merenstein &amp; Gardner’s handbook of neonatal intensive care nursing: an interprofessional approach</span>. .</span></span> </li>
<li>
<span id="sutherland2015a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P, <i>et al.</i></b></span>. <span style="font-variant: normal">AKI in Hospitalized Children: Comparing the pRIFLE, AKIN, and KDIGO Definitions</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Clin J Am Soc Nephrol</i></span> <span style="text-decoration: none">2015; <b>10</b> (4)</span>: <span style="text-decoration: none">554–561</span>. <span style="text-decoration: underline">DOI: 10.2215/cjn.01900214</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/25649155/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.2215/cjn.01900214" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="kdigokakiw2012a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Khwaja A</b></span>. <span style="font-variant: normal">KDIGO Clinical Practice Guidelines for Acute Kidney Injury</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Nephron Clin Pract</i></span> <span style="text-decoration: none">2012; <b>120</b> (4)</span>: <span style="text-decoration: none">c179–c184</span>. <span style="text-decoration: underline">DOI: 10.1159/000339789</span></span>.</span></span>   <a href="https://doi.org/10.1159/000339789" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="selewski2015a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Selewski DT, Charlton JR, Jetton JG, Guillet R, Mhanna MJ, Askenazi DJ, <i>et al.</i></b></span>. <span style="font-variant: normal">Neonatal Acute Kidney Injury</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatrics</i></span> <span style="text-decoration: none">2015; <b>136</b> (2)</span>: <span style="text-decoration: none">e463–e473</span>. <span style="text-decoration: underline">DOI: 10.1542/peds.2014-3819</span></span>.</span></span>   <a href="https://doi.org/10.1542/peds.2014-3819" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="sandokji2020a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Sandokji I, Greenberg JH</b></span>. <span style="font-variant: normal">Novel biomarkers of acute kidney injury in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Curr Opin Pediatr</i></span> <span style="text-decoration: none">2020; <b>32</b> (3)</span>: <span style="text-decoration: none">354–359</span>. <span style="text-decoration: underline">DOI: 10.1097/mop.0000000000000891</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/32332324/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/mop.0000000000000891" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="stanski2019a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Stanski N, Menon S, Goldstein SL, Basu RK</b></span>. <span style="font-variant: normal">Integration of urinary neutrophil gelatinase-associated lipocalin with serum creatinine delineates acute kidney injury phenotypes in critically ill children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Crit Care</i></span> <span style="text-decoration: none">2019; <b>53</b></span>: <span style="text-decoration: none">1–7</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jcrc.2019.05.017</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/31174170/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jcrc.2019.05.017" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="goldstein2013a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Goldstein SL, Kirkendall E, Nguyen H, Schaffzin JK, Bucuvalas J, Bracke T, <i>et al.</i></b></span>. <span style="font-variant: normal">Electronic Health Record Identification of Nephrotoxin Exposure and Associated Acute Kidney Injury</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatrics</i></span> <span style="text-decoration: none">2013; <b>132</b> (3)</span>: <span style="text-decoration: none">e756–e767</span>. <span style="text-decoration: underline">DOI: 10.1542/peds.2013-0794</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/23940245/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1542/peds.2013-0794" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="musu2011a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Musu M, Finco G, Antonucci R</b></span>. <span style="font-variant: normal">NSAID Nephrotoxicity Revisited: Acute Renal Failure Due to Parenteral Ketorolac</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>South Med J</i></span> <span style="text-decoration: none">2011; <b>86</b> (12)</span>: <span style="text-decoration: none">1421–1424</span>. <span style="text-decoration: underline">DOI: 10.1097/00007611-199312000-00025</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/22288307/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/00007611-199312000-00025" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="bellos2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Bellos I, Pandita A, Yachha M</b></span>. <span style="font-variant: normal">Effectiveness of theophylline administration in neonates with perinatal asphyxia: a meta-analysis</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Matern Fetal Neonatal Med</i></span> <span style="text-decoration: none">2021; <b>34</b> (18)</span>: <span style="text-decoration: none">3080–3088</span>. <span style="text-decoration: underline">DOI: 10.1080/14767058.2019.1673722</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/31558088/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1080/14767058.2019.1673722" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="feld2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Feld LG, Neuspiel DR, Foster BA</b></span>. <span style="font-variant: normal">Clinical Practice Guideline: Maintenance Intravenous Fluids in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatric Clinical Practice Guidelines &amp;Amp; Policies</i></span> <span style="text-decoration: none">2018; <b>142</b> (6)</span>: <span style="text-decoration: none">375–388</span>. <span style="text-decoration: underline">DOI: 10.1542/9781610026086-part01-21</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/30478247/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1542/9781610026086-part01-21" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="yitzhaki2000a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Vanhaesebrouck P, Carton D, De Bel C, Praet M, Proesmans W</b></span>. <span style="font-variant: normal">Acute Tubulo-Interstitial Nephritis and Uveitis Syndrome (TINU Syndrome)</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Nephron</i></span> <span style="text-decoration: none">2000; <b>40</b> (4)</span>: <span style="text-decoration: none">418–422</span>. <span style="text-decoration: underline">DOI: 10.1159/000183511</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/10883133/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1159/000183511" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="chevalier2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Hayashi A, Takahashi T, Ueda Y, Sato Y, Okamoto T</b></span>. <span style="font-variant: normal">Long-term clinical characteristics and renal prognosis of children with tubulointerstitial nephritis and uveitis syndrome</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2021</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-021-04956-6</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/34901573/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-021-04956-6" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="lamb2013a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lamb EJ, Levey AS, Stevens PE</b></span>. <span style="font-variant: normal">The Kidney Disease Improving Global Outcomes (KDIGO) Guideline Update for Chronic Kidney Disease: Evolution not Revolution</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Clin Chem</i></span> <span style="text-decoration: none">2013; <b>59</b> (3)</span>: <span style="text-decoration: none">462–465</span>. <span style="text-decoration: underline">DOI: 10.1373/clinchem.2012.184259</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/23449698/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1373/clinchem.2012.184259" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="group2009a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Group ET, Wuhl E, Trivelli A</b></span>. <span style="font-variant: normal">Foreign Article Review : Strict Blood-Pressure Control and Progression of Renal Failure in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Nihon Shoni Jinzobyo Gakkai Zasshi</i></span> <span style="text-decoration: none">2009; <b>23</b> (1)</span>: <span style="text-decoration: none">54–55</span>. <span style="text-decoration: underline">DOI: 10.3165/jjpn.23.54</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/19846849/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3165/jjpn.23.54" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="atkinson2015a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL</b></span>. <span style="font-variant: normal">Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2015; <b>30</b> (4)</span>: <span style="text-decoration: none">635–643</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-014-2991-4</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/25380788/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-014-2991-4" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="mitsnefes2012a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Mitsnefes MM</b></span>. <span style="font-variant: normal">Cardiovascular Disease in Children with Chronic Kidney Disease</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Adv Chronic Kidney Dis</i></span> <span style="text-decoration: none">2012; <b>12</b> (4)</span>: <span style="text-decoration: none">397–405</span>. <span style="text-decoration: underline">DOI: 10.1053/j.ackd.2005.07.005</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/22383696/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1053/j.ackd.2005.07.005" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="wesseling-perry2013a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Bakkaloglu SA, Wesseling-Perry K, Salusky IB</b></span>. <span style="font-variant: normal">Chronic kidney disease-mineral and bone disorder (CKD-MBD) in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease</i></span> <span style="text-decoration: none">2013; <b>3</b> (2)</span>: <span style="text-decoration: none">485–507</span>. <span style="text-decoration: underline">DOI: 10.1093/med/9780199559176.003.028</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/23465503/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1093/med/9780199559176.003.028" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="kumar2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, <i>et al.</i></b></span>. <span style="font-variant: normal">Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2016; <b>31</b> (1)</span>: <span style="text-decoration: none">121–129</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-015-3190-7</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26307635/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-015-3190-7" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="goldstein2007a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Goldstein SL, Gerson AC, Furth S</b></span>. <span style="font-variant: normal">Health-Related Quality of Life for Children With Chronic Kidney Disease</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Adv Chronic Kidney Dis</i></span> <span style="text-decoration: none">2007; <b>14</b> (4)</span>: <span style="text-decoration: none">364–369</span>. <span style="text-decoration: underline">DOI: 10.1053/j.ackd.2007.07.006</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/17904504/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1053/j.ackd.2007.07.006" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="warady2020a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Warady BA, Schaefer F, Bagga A, Cano F, McCulloch M, Yap H-K, <i>et al.</i></b></span>. <span style="font-variant: normal">Prescribing peritoneal dialysis for high-quality care in children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Perit Dial Int</i></span> <span style="text-decoration: none">2020; <b>40</b> (3)</span>: <span style="text-decoration: none">333–340</span>. <span style="text-decoration: underline">DOI: 10.1177/0896860819893805</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/32063210/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1177/0896860819893805" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="atkinson2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Atkinson MA, Ng DK, Warady BA, Furth SL, Flynn JT</b></span>. <span style="font-variant: normal">The CKiD study: overview and summary of findings related to kidney disease progression</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatr Nephrol</i></span> <span style="text-decoration: none">2021; <b>36</b> (3)</span>: <span style="text-decoration: none">527–538</span>. <span style="text-decoration: underline">DOI: 10.1007/s00467-019-04458-6</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/32016626/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s00467-019-04458-6" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="zeidel2014a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Zeidel ML, Hoenig MP</b></span>. <span style="font-variant: normal">Cardiac Physiology for the Clinician</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Jama</i></span> <span style="text-decoration: none">2014; <b>235</b> (26)</span>: <span style="text-decoration: none">2865</span>. <span style="text-decoration: underline">DOI: 10.1001/jama.1976.03260520057032</span></span>.</span></span>   <a href="https://doi.org/10.1001/jama.1976.03260520057032" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
</ol>


            
            <!--Last repository commit: 3ddc96e6e-->
            <p class="last-modified"><i class="fas fa-clock pr-2"></i><em>Last updated: 2023-02-22 15:40</em></p>
          </div> <!-- /col -->
        </div> <!-- /row -->
      </div> <!-- /container -->
    </div> <!-- /main -->
    
    <footer id="footer">
      <div class="container">
        <div class="row py-5">
          <div class="col-md-4 d-flex justify-content-center justify-content-md-start mb-4 mb-lg-0">
            <a href="https://pediatricurologybook.com/" class="logo pr-0 pr-lg-3 pl-3 pl-md-0">
                <img alt="Pediatric Urology Book" class="img-responsive" src="https://pediatricurologybook.com/assets/site-img/pediatricurologybook-white.svg">
            </a>
          </div>
        </div>
      </div>
      <div class="footer-copyright footer-copyright-style-2">
        <div class="container py-2">
          <div class="row py-4">
            <div class="col-lg-4 d-flex align-items-end justify-content-center justify-content-md-start mb-2 mb-lg-0">
              <p>© 2024 by <a href="https://pediatricurologybook.com/">Pediatric Urology Book</a>. All Rights Reserved.</p>
            </div>
            <div class="col-lg-8 d-flex flex-column mb-4 mb-lg-0">
              <div class="row">
                <div class="col-12 d-flex align-items-center justify-content-center justify-content-md-end m-0 p-0"><ul class="footer-social-icons social-icons social-icons-clean social-icons-icon-light"><li class="social-icons-github"><a href="https://www.github.com/kylerove/pediatricurologybook" target="_blank" title="GitHub"><i class="fab fa-github-alt"></i></a></li><li class="social-icons-twitter"><a href="https://www.twitter.com/PedUrologyBook" target="_blank" title="Twitter"><i class="fab fa-twitter"></i></a></li><li class="social-icons-mastodon"><a rel="me" href="https://med-mastodon.com/@pediatricurologybook" target="_blank" title="Mastodon"><i class="fab fa-mastodon"></i></a></li><li class="social-icons-youtube"><a href="https://www.youtube.com/@pediatricurologybook" target="_blank" title="Youtube"><i class="fab fa-youtube"></i></a></li></ul></div>
              </div>
              <div class="row">
                <div class="col-12 d-flex align-items-center justify-content-center justify-content-md-end m-0 p-0">
                  <nav id="sub-menu">
                    <ul>
                      <li><i class="fas fa-map-marker"></i> <a href="https://pediatricurologybook.com/site-map/">Site Map</a></li><li><i class="fas fa-envelope"></i><a href="mailto:editors%40pediatricurologybook.com" class="opacity-7 pl-1">editors@pediatricurologybook.com</a></li></ul>
                  </nav>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </footer>
</div>
    
    <!-- Search -->
    <script src="https://pediatricurologybook.com/assets/js/search.min.js"></script>
    
    <!-- Vendor -->
    <script src="https://pediatricurologybook.com/assets/vendor/jquery/jquery.min.js"></script>
    <script src="https://pediatricurologybook.com/assets/vendor/jquery.appear/jquery.appear.min.js"></script>
    <script src="https://pediatricurologybook.com/assets/vendor/jquery.easing/jquery.easing.min.js"></script>
    <script src="https://pediatricurologybook.com/assets/vendor/jquery.validation/jquery.validate.min.js"></script>
    <script src="https://pediatricurologybook.com/assets/vendor/jquery.stupidtable/stupidtable.min.js"></script>
    <script src="https://pediatricurologybook.com/assets/vendor/popper/umd/popper.min.js"></script>
    <script src="https://pediatricurologybook.com/assets/vendor/bootstrap/js/bootstrap.min.js"></script>
    
    <!-- Theme Base, Components and Settings -->
    <script src="https://pediatricurologybook.com/assets/js/theme.js"></script>
    
    <!-- Current Page --><script src="https://pediatricurologybook.com/assets/js/pages/chapter.js"></script>
    
    
    <!-- Theme Custom -->
    <script src="https://pediatricurologybook.com/assets/js/custom.js"></script>
    
    <!-- Theme Initialization Files -->
    <script src="https://pediatricurologybook.com/assets/js/theme.init.js"></script>
    
    <!-- Scroll to top -->
    <a class="scroll-to-top hidden-mobile" href="#"><i class="fas fa-chevron-up"></i></a>
    
  </body>
</html>
